China Money Network
Login
Join
Search
Close this search box.

Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma

Login to View
  • June 12, 2024 β€” 02:15 CST
China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LinkedIn
Facebook
Telegram
WhatsApp
Reddit
X
Related Topics:

Related News:

Franchising and Licensing Asia (FLAsia) 2024